Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Duployez

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNANicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
Bulletin Du Cancer|January 24, 2024
[Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers]Marion Strullu, Elie Cousin, Sandrine de Montgolfier, et al.
Genes, Chromosomes & Cancer|May 13, 2024
Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemiaCharlotte Ragnarsson, Minjun Yang, Larissa Helena Moura-Castro, et al.
Leukemia & Lymphoma|January 9, 2019
Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: a case report and review of the literatureElise Fournier, Luca Inchiappa, Carole Delattre, et al.
Haematologica|June 20, 2020
Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trialLaurène Fenwarth, Nicolas Duployez, Alice Marceau-Renaut, et al.
Leukemia|December 13, 2019
Familial myeloid malignancies with germline TET2 mutationNicolas Duployez, Laure Goursaud, Laurène Fenwarth, et al.
Blood Advances|October 29, 2021
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experienceAva Diarra, Nicolas Duployez, Elise Fournier, et al.
Haematologica|April 27, 2023
<i>TET2</i> mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemiaViolaine Tran Quang, Benjamin Podvin, Christophe Desterke, et al.
Oncotarget|December 30, 2017
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromesMathieu Meunier, Sarah Ancelet, Christine Lefebvre, et al.
Leukemia|October 18, 2022
Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignanciesMelanie Decker, Tim Lammens, Alina Ferster, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNANicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
Bulletin Du Cancer|January 24, 2024
[Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers]Marion Strullu, Elie Cousin, Sandrine de Montgolfier, et al.
Genes, Chromosomes & Cancer|May 13, 2024
Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemiaCharlotte Ragnarsson, Minjun Yang, Larissa Helena Moura-Castro, et al.
Leukemia & Lymphoma|January 9, 2019
Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: a case report and review of the literatureElise Fournier, Luca Inchiappa, Carole Delattre, et al.
Haematologica|June 20, 2020
Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trialLaurène Fenwarth, Nicolas Duployez, Alice Marceau-Renaut, et al.
Leukemia|December 13, 2019
Familial myeloid malignancies with germline TET2 mutationNicolas Duployez, Laure Goursaud, Laurène Fenwarth, et al.
Blood Advances|October 29, 2021
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experienceAva Diarra, Nicolas Duployez, Elise Fournier, et al.
Haematologica|April 27, 2023
<i>TET2</i> mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemiaViolaine Tran Quang, Benjamin Podvin, Christophe Desterke, et al.
Oncotarget|December 30, 2017
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromesMathieu Meunier, Sarah Ancelet, Christine Lefebvre, et al.
Leukemia|October 18, 2022
Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignanciesMelanie Decker, Tim Lammens, Alina Ferster, et al.
Pageof 15